- Home
- IMTE vs XRTX Comparison
IMTE vs XRTX Comparison
Compare IMTE & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- XRTX
- Stock Information
- Founded
- IMTE 2008
- XRTX 2011
- Country
- IMTE Malaysia
- XRTX Canada
- Employees
- IMTE N/A
- XRTX N/A
- Industry
- IMTE Consumer Electronics/Appliances
- XRTX Pharmaceuticals and Biotechnology
- Sector
- IMTE Consumer Staples
- XRTX Health Care
- Exchange
- IMTE Nasdaq
- XRTX Nasdaq
- Market Cap
- IMTE 4.1M
- XRTX 3.4M
- IPO Year
- IMTE N/A
- XRTX N/A
- Fundamental
- Price
- IMTE $1.06
- XRTX $0.96
- Analyst Decision
- IMTE
- XRTX
- Analyst Count
- IMTE 0
- XRTX 0
- Target Price
- IMTE N/A
- XRTX N/A
- AVG Volume (30 Days)
- IMTE 73.3K
- XRTX 224.7K
- Earning Date
- IMTE 07-22-2025
- XRTX 08-13-2025
- Dividend Yield
- IMTE N/A
- XRTX N/A
- EPS Growth
- IMTE N/A
- XRTX N/A
- EPS
- IMTE N/A
- XRTX N/A
- Revenue
- IMTE $123,337.00
- XRTX N/A
- Revenue This Year
- IMTE N/A
- XRTX N/A
- Revenue Next Year
- IMTE N/A
- XRTX N/A
- P/E Ratio
- IMTE N/A
- XRTX N/A
- Revenue Growth
- IMTE 4.75
- XRTX N/A
- 52 Week Low
- IMTE $0.51
- XRTX $0.80
- 52 Week High
- IMTE $3.17
- XRTX $2.98
- Technical
- Relative Strength Index (RSI)
- IMTE 47.89
- XRTX 54.93
- Support Level
- IMTE $1.00
- XRTX $0.81
- Resistance Level
- IMTE $1.13
- XRTX $0.93
- Average True Range (ATR)
- IMTE 0.10
- XRTX 0.08
- MACD
- IMTE 0.01
- XRTX 0.01
- Stochastic Oscillator
- IMTE 69.33
- XRTX 68.20
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.